Answer a few questions to see if you may be a candidate for the AIRFLOW-3 Clinical Trial, which is investigating Targeted Lung Denervation (TLD).
Are you between 40-78 years of age?
Have you been diagnosed with COPD, and are you taking daily medications to manage your symptoms?
Have you stopped smoking and will continue not to smoke?
Have you been to the Emergency Room or been hospitalized for COPD flare-ups in the past year?
Have you seen your doctor and been required to take additional medications for COPD flare-ups in the past year?
Are you willing to undergo a
bronchoscopic procedure During a bronchoscopic procedure, a thin, lighted tube with a small camera at the tip (a bronchoscope) is passed through your mouth down your throat and into your lungs. The bronchoscope allows a specialized lung doctor to see into your lungs and deliver treatment.
as part of this COPD research study?

By clicking “submit” you are granting permission to Nuvaira and/or a Nuvaira representative to send the information you have provided to the study site nearest to you so that they may contact you regarding the AIRFLOW-3 clinical trial.